Last reviewed · How we verify
NCT05027659
The Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing Colonoscopy
NA trial testing virtual reality glasses in Vital Signs in 44 participants. Completed in 20 December 2020.
28 September 2020
Quick facts
| Lead sponsor | Esra DOĞAN YILMAZ, RN, MSc |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 44 |
| Start date | 2 January 2020 |
| Primary completion | 28 September 2020 |
| Estimated completion | 20 December 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- virtual reality glasses
Conditions studied
- Vital Signs — all drugs for Vital Signs →
- Anxiety — all drugs for Anxiety →
- Colonoscopy — all drugs for Colonoscopy →
Sponsor
Esra DOĞAN YILMAZ, RN, MSc
Who can join
Adults 18 to 79, any sex, with Vital Signs or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study was conducted with 44 patients who applied to the Endoscopy Unit of a university hospital for sedation-free colonoscopy between January 2, 2020 and September 28, 2020, met the inclusion criteria and agreed to participate in the study. The patients were homogeneously divided into experimental (n=22) and control (n=22) groups based on their gender and history of colonoscopy. The patients in the experimental group watched a 360 degree virtual reailty (VR) video with atmospheric background music over images and sounds of nature through virtual reality glasses while no application was performed for the patients in the control group during the procedure. The "Demographic Information Form", "Trait Anxiety Scale", "Visual Analog Scale-Pain", "Visual Analog Scale-Anxiety", "Vital Signs Monitoring Chart" and "Satisfaction Evaluation on the Virtual Reality Glasses Application" forms were used in the data collection phase. For the study, an ethics committee approval was obtained in addition to written consent by the institutions and patients. Numbers, percentages, the Chi-square test, the Wilcoxon test and the Mann-Whitney U test were used for data analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05027659
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of virtual reality glasses
Trials testing the same drug.
- NCT07283432 — Effect of Education Given With Virtual Reality Glasses on Self-Care Ability of Patients After Bariatric Surgery · NA · completed
- NCT07393737 — The Effect of Using Virtual Reality and Kaleidoscope During Renal Scintigraphy on Children's Fear and Anxiety · NA · enrolling by invitation
- NCT07471152 — The Effect of Virtual Reality Goggles on Perceived Stress, Anxiety, and Fatigue in Nurses Working in Intensive Care Unit · NA · completed
- NCT07008625 — the Effect of Virtual Reality Glasses on Women Who Milk Their Babies by Milking · NA · not yet recruiting
- NCT06760689 — Brief Title- Virtual Reality Glasses in Gynecologic Cancer · NA · enrolling by invitation
Other recruiting trials for Vital Signs
Currently open trials in the same condition.
- NCT07488390 — Escape Room Simulation vs Case-Based Learning for Vital Sign Measurement in Nursing Students · NA · active not recruiting
- NCT07322731 — The Effect of Massage on Sleep Quality, Stress, Comfort, and Vital Signs in Preterm Infants · NA · recruiting
- NCT05451875 — Validation of Vital Signs Recording With VT-Patch Connected Devices in Children · recruiting
- NCT04627766 — Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch · NA · recruiting
- NCT07080281 — Evaluating the Effectiveness of Virtual Reality Application in Caesarean Section · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05027659 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Esra DOĞAN YILMAZ, RN, MSc
- Last refreshed: 30 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05027659.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing